Stephen E Kurtz

10PUBLICATIONS
74CO-AUTHORS
Predictive and prognostic markersGene and molecular therapyMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Nov 24, 2025
A Rapid Gene Expression Profiler Classifies AML Tumor Responsiveness to Standard Therapies.

Stephen E Kurtz, Christopher A Eide, Andy Kaempf

|May 21, 2025
Genetic and Phenotypic Correlates of Clinical Outcomes with Venetoclax in Acute Myeloid Leukemia: The GEN-PHEN-VEN Study.

Curtis A Lachowiez, Mael Heiblig, Gaspar Aspas Requena

|Mar 07, 2024
Targeting CCL2/CCR2 Signaling Overcomes MEK Inhibitor Resistance in Acute Myeloid Leukemia.

Rucha V Modak, Katia G de Oliveira Rebola, John McClatchy

|Sep 12, 2023
Clinical Correlates of Venetoclax-Based Combination Sensitivities to Augment Acute Myeloid Leukemia Therapy.

Christopher A Eide, Stephen E Kurtz, Andy Kaempf

|May 02, 2022
Luxeptinib (CG-806) Targets FLT3 and Clusters of Kinases Operative in Acute Myeloid Leukemia.

William G Rice, Stephen B Howell, Hongying Zhang

Pageof 2